ASCP Mission Statement
The mission of the American Society of Clinical Psychopharmacology is to advance the science and practice of clinical psychopharmacology.
ASCP Diversity Statement
The organization has a commitment to actively promote and welcome diversity and inclusion within the society and within our field. Diversity includes but is not limited to race, ethnicity, religion, disability, age, sex, gender identity, sexual orientation, intellectual perspectives and points of view.
ASCP Underrepresented in Biomedical Sciences Statement
ASCP URB (Underrepresented in Biomedical Sciences): Groups underrepresented within biomedical sciences are currently defined as African American, Hispanic, Native American, Pacific Islander, or Scientist with a Disability.
- to provide continuing education, e.g., reviews, updates, presentation of new findings, for practicing psychopharmacologists;
- to encourage interest in and support training in psychopharmacology for medical students, psychiatric residents and fellows;
- to encourage clinically relevant research in psychopharmacology and the rapid dissemination of new findings;
- to facilitate exchange of information among senior psychopharmacologists and other investigators in the field and the exchange of information and discussion between investigators and practitioners of psychopharmacology;
- to stimulate and encourage young investigators interested in psychopharmacology;
In other professional areas
- to establish liaisons with, and complement the efforts of, other related professional organizations, e.g., APA, ACNP, Biological Psychiatry;
In nonprofessional areas
- to develop constructive relationships with mental health advocacy groups; and
- to advocate public policies which promote clinical research of psychiatric disorders and the delivery of high quality patient care.